Stability of [123I]IBZM SPECT measurement of amphetamine-induced striatal dopamine release in humans
- 15 March 1999
- Vol. 31 (4) , 302-308
- https://doi.org/10.1002/(sici)1098-2396(19990315)31:4<302::aid-syn9>3.0.co;2-a
Abstract
Binding competition between endogenous dopamine (DA) and the D2 receptor radiotracer [123I]IBZM allows measurement of the change in synaptic DA following amphetamine challenge with SPECT in the living human brain. Previous investigations using this technique in healthy subjects have shown that the magnitude of amphetamine effect on [123I]IBZM binding potential (BP) is small (range between 5 to 15% decrease), and that a large between-subject variability in this effect is observed. Therefore, it was unclear how much of the apparent between-subject variability was due to a low signal-to-noise ratio in the measurement, vs. true between-subject differences in the magnitude of the response. The goals of this investigation were to test the within-subject reproducibility and reliability of amphetamine-induced decrease in [123I]IBZM BP with a test/retest paradigm, and to establish the presence or absence of tolerance or sensitization to single administration ofi.v. amphetamine. Six healthy male subjects, never previously exposed to psychostimulants, twice underwent measurement of striatal amphetamine-induced DA release (between-measurement interval 16 +/- 10 days) using SPECT and the [123I]IBZM constant infusion technique. Results demonstrated an excellent within-subject reproducibility of amphetamine-induced DA release: amphetamine-induced decreases in [123I]IBZM BP were significant on each day, and had an intraclass correlation coefficient (ICC) of 0.89. Moreover, values from the second experiment were not significantly different from first experiment, suggesting the absence of either sensitization or tolerance to the effect of amphetamine on DA release in these experimental conditions. The subjective activation, as rated by the subjects on analog scales, was also highly reproducible. In conclusion, this scanning technique provides a reliable measurement of amphetamine-induced reduction of [123I]IBZM BP and enables detection of between-subject differences that appear stable over time.Keywords
This publication has 34 references indexed in Scilit:
- Alterations of Benzodiazepine Receptors in Type II Alcoholic Subjects Measured With SPECT and [123I]IomazenilAmerican Journal of Psychiatry, 1998
- Quantification of Amphetamine-Induced Changes in [11C]Raclopride Binding with Continuous InfusionJournal of Cerebral Blood Flow & Metabolism, 1997
- Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: Evidence from a novel positron emission tomography methodProceedings of the National Academy of Sciences, 1997
- The tonic/phasic model of dopamine system regulation: its relevance for understanding how stimulant abuse can alter basal ganglia functionDrug and Alcohol Dependence, 1995
- Sex differences in striatal dopamine: in vivo microdialysis and behavioral studiesBrain Research, 1993
- Endogenous Dopamine (Da) Modulates [3H]spiperone Binding in Vivo in Rat BrainJournal of Receptor Research, 1991
- Estrogen rapidly potentiates amphetamine-induced striatal dopamine release and rotational behavior during microdialysisNeuroscience Letters, 1990
- Positron emission tomography (PET) studies of dopaminergic/cholinergic interaction in the baboon brainSynapse, 1990
- Enhanced extracellular dopamine level may be the fundamental neuropharmacological basis of cross-behavioral sensitization between methamphetamine and cocaine — an in vivo dialysis study in freely moving ratsBrain Research, 1990
- Estrous cycle-dependent variation in amphetamine-induced behaviors and striatal dopamine release assessed with microdialysisBehavioural Brain Research, 1989